Ian J Jacobs

Ian J Jacobs

UNVERIFIED PROFILE

Are you Ian J Jacobs?   Register this Author

Register author
Ian J Jacobs

Ian J Jacobs

Publications by authors named "Ian J Jacobs"

Are you Ian J Jacobs?   Register this Author

76Publications

1604Reads

29Profile Views

Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis.

Menopause 2019 Oct;26(10):1100-1009

Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791508PMC
October 2019

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

J Clin Oncol 2017 May 27;35(13):1411-1420. Epub 2017 Feb 27.

Adam N. Rosenthal, Lindsay S.M. Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Andy Ryan, Robert Liston, Jeremy Ford, Richard Gunu, Usha Menon, and Ian J. Jacobs, University College London Elizabeth Garrett Anderson Institute for Women's Health; Elizabeth Benjamin, University College London; Naveena Singh, Barts Health National Health Service Trust; Ranjit Manchanda, Barts Cancer Institute, Queen Mary University of London; Anne Dawnay, University College London Hospital; James Mackay, The University College London Cancer Institute, London; D. Gareth Evans, University of Manchester, St Mary's Hospital Manchester, Manchester; Diana M. Eccles, Southampton General Hospital, Southampton, United Kingdom; Steven J. Skates, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and Ian J. Jacobs, University of New South Wales Australia, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.9330
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.9330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455461PMC
May 2017

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.

Br J Cancer 2017 Feb 12;116(4):501-508. Epub 2017 Jan 12.

Department of Women's Cancer, Institute for Women's Health, University College London, London, W1T 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318971PMC
February 2017

Ovarian cancer screening: UKCTOCS trial - Authors' reply.

Lancet 2016 Jun;387(10038):2603-2604

Department of Women's Cancer, Institute for Women's Health, University College London, London W1T 7DN, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)30849-2DOI Listing
June 2016

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.

J Natl Cancer Inst 2015 Nov 27;107(11). Epub 2015 Aug 27.

Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA (SJR, MPI, CKE, DC, SAG); CR-UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (HS, ED, JPT, PH, JA, PDPP); Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK (ANR, LF, AGM, JH, SP, CA, UM, IJJ); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (DB, ACA); Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia (DDB, KA, GM, AOCSSG); Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia (DDB); Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia (DDB, GM); Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK (DDB); Westmead Millennium Institute, Westmead Hospital, Sydney, Australia (AOCSSG); The QIMR Berghofer Medical Research Institute, Brisbane, Australia (AOCSSG); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (MSC, JMC, ELG); Department of Biostatistics, University of Kansas Medical Center, Andover, KS (BLF); Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK (MJL); Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY (SP, SL, KO); Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY (LSC, KBM); Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA (WS, VM, ASW); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center (JL, BYK); Gynaecology Research Unit, Hannover Medical School, Hannover, Germany (NB, TD); Radiation Oncology Research Unit, Hannover Medical School, Hannover,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643629PMC
November 2015

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

J Clin Oncol 2015 Sep 10;33(26):2901-7. Epub 2015 Aug 10.

Honglin Song, Ed Dicks, Jonathan P. Tyrer, Patricia Harrington, Jennifer Alsop, and Paul D.P. Pharoah, University of Cambridge; Mercedes Jimenez-Linan, Addenbrooke's Hospital, Cambridge; Jane Hayward, Lindsay Fraser, Susan Philpott, Christopher Anderson, Adam Rosenthal, Aleksandra Gentry-Maharaj, Usha Menon, and Ian J. Jacobs, University College London; David D. Bowtell, Imperial College London, London; Ian J. Jacobs, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom; Susan J. Ramus, Maria P. Intermaggio, Christopher K. Edlund, David Conti, and Simon A. Gayther, University of Southern California, Los Angeles, CA; David D. Bowtell and Kathryn Alsop, Peter MacCallum Cancer Centre, East Melbourne; David D. Bowtell, University of Melbourne, Melbourne, Victoria, Australia; Mine S. Cicek, Julie M. Cunningham, and Ellen L. Goode, Mayo Clinic, Rochester, MN; Brooke L. Fridley, University of Kansas Medical Center, Kansas City, KS; Estrid Høgdall, Allan Jensen, and Susanne Krüger, Danish Cancer Society Research Center; Estrid Høgdall, Herlev Hospital, University of Copenhagen; Claus K. Høgdall and Susanne Krüger, Rigshospitalet, Copenhagen, Denmark; Jan Lubiński, Tomasz Huzarski, Anna Jakubowska, and Jacek Gronwald, Pomeranian Medical University, Szczecin, Poland; and Samantha Poblete, Shashi Lele, Lara Sucheston-Campbell, Kirsten B. Moysich, and Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.2408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554751PMC
September 2015

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

BJOG 2014 Dec;121 Suppl 7:35-9

Gynaecology Cancer Research Unit, St Bartholomew's Hospital, The Royal Hospitals NHS Trust, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1471-0528.13211DOI Listing
December 2014

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.

Genome Med 2014 27;6(6):47. Epub 2014 Jun 27.

Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, 74 Huntley Street, London WC1E 6 AU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110671PMC
July 2014

Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.

J Med Genet 2014 Feb 25;51(2):108-13. Epub 2013 Nov 25.

Department of Public and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2013-102015DOI Listing
February 2014

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.

Lancet Oncol 2013 Nov 17;14(12):1226-32. Epub 2013 Oct 17.

Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70448-0DOI Listing
November 2013

In vitro three-dimensional modeling of fallopian tube secretory epithelial cells.

BMC Cell Biol 2013 Sep 27;14:43. Epub 2013 Sep 27.

Department of Preventive Medicine, University of Southern California/Keck School of Medicine, 1450 Biggy Street, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2121-14-43DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849984PMC
September 2013

Genetic and cellular mechanisms regulating anterior foregut and esophageal development.

Dev Biol 2012 Sep 27;369(1):54-64. Epub 2012 Jun 27.

Department of Biology, University of Rochester, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2012.06.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409292PMC
September 2012

Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.

Carcinogenesis 2011 Oct 22;32(10):1540-9. Epub 2011 Aug 22.

UCL EGA Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgr140DOI Listing
October 2011

DNA methylation analysis in liquid-based cytology for cervical cancer screening.

Int J Cancer 2009 Dec;125(12):2995-3002

Department of Gynecological Oncology, Institute for Women's Health, University College London, London WC1E 6DH, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24745DOI Listing
December 2009

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

Nat Genet 2009 Sep 2;41(9):996-1000. Epub 2009 Aug 2.

Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844110PMC
September 2009

The clonal evolution of metastases from primary serous epithelial ovarian cancers.

Int J Cancer 2009 Apr;124(7):1579-86

Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24148DOI Listing
April 2009

Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells.

Int J Cancer 2009 Mar;124(5):1037-44

Gynaecological Cancer Research Laboratory, UCL EGA Institute for Women's Health, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24058DOI Listing
March 2009

Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma.

Ann Surg Oncol 2008 Sep 12;15(9):2581-8. Epub 2008 Jul 12.

Cancer Research-United Kingdom Translational Oncology Laboratory, St. Bartholomew's and the Royal London School of Medicine and Dentistry, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-0014-zDOI Listing
September 2008

Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.

Clin Cancer Res 2008 Sep;14(18):5840-8

Gynaecological Cancer Research Laboratory, University College London Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0373DOI Listing
September 2008

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.

Int J Cancer 2008 Aug;123(3):725-9

Department of Gynecological Oncology, UCL EGA Institute for Women's Health, University College London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23563DOI Listing
August 2008

Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study.

Pathology 2008 Aug;40(5):487-92

Department of Virus, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020802197889DOI Listing
August 2008

Distribution of microsatellite instability in Danish ovarian tumor patients and the prognostic value in ovarian cancer patients.

Oncol Res 2008 ;17(1):43-9

Gynaecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen O, DK-2100, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3727/096504008784046090DOI Listing
July 2008

OSPACS: Ultrasound image management system.

Source Code Biol Med 2008 Jun 20;3:11. Epub 2008 Jun 20.

Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women's Health, University College London, Paul O'Gorman Building, Gower Street, London WC1E 6BT, UK.

View Article

Download full-text PDF

Source
http://scfbm.biomedcentral.com/articles/10.1186/1751-0473-3-
Publisher Site
http://dx.doi.org/10.1186/1751-0473-3-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442597PMC
June 2008

A suite of Perl modules for handling microarray data.

Bioinformatics 2008 Apr 18;24(8):1102-3. Epub 2008 Mar 18.

Translational Research Laboratories, UCL EGA Institute for Women's Health, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
https://academic.oup.com/bioinformatics/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/bioinformatics/btn085DOI Listing
April 2008

A Perl toolkit for LIMS development.

Source Code Biol Med 2008 Mar 19;3. Epub 2008 Mar 19.

Translational Research Laboratories, UCL EGA Institute for Women's Health, University College London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1751-0473-3-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322998PMC
March 2008

Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.

Hum Mutat 2007 Dec;28(12):1207-15

Translational Research Laboratory, University College London (UCL), Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.20599DOI Listing
December 2007

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.

Gynecol Oncol 2007 Dec 24;107(3):526-31. Epub 2007 Oct 24.

Center for Biomarker Discovery, Department of Pathology, Johns Hopkins Medical Institutions, CRB-II 3M04, 1550 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2171045PMC
December 2007

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.

Oncol Rep 2007 Nov;18(5):1051-9

Department of Virus, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
November 2007

Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.

Gynecol Oncol 2007 Aug 31;106(2):318-24. Epub 2007 May 31.

Department of Virus, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.03.043DOI Listing
August 2007

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.

Gynecol Oncol 2007 Mar 17;104(3):508-15. Epub 2006 Nov 17.

Department of Virus, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580600741
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2006.09.028DOI Listing
March 2007

Screening for ovarian cancer.

Clin Obstet Gynecol 2006 Sep;49(3):433-47

Institute for Women's Health, University College London, Elizabeth Garrett Anderson Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00003081-200609000-00004DOI Listing
September 2006

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

J Clin Oncol 2005 Nov;23(31):7919-26

Department of Gynecological Oncology, Institute of Women's Health, University College London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.6642DOI Listing
November 2005

Low frequency of BRAF and CDKN2A mutations in endometrial cancer.

Int J Cancer 2005 Jul;115(6):930-4

Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.20702
Publisher Site
http://dx.doi.org/10.1002/ijc.20702DOI Listing
July 2005

STK15 polymorphisms and association with risk of invasive ovarian cancer.

Cancer Epidemiol Biomarkers Prev 2004 Oct;13(10):1589-94

Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
October 2004

A molecular genetic and statistical approach for the diagnosis of dual-site cancers.

J Natl Cancer Inst 2004 Oct;96(19):1441-6

Gynaecology Cancer Research Unit, St. Bartholomew's and The London, Queen Mary's School of Medicine and Dentistry, University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djh272DOI Listing
October 2004

A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro.

Lab Invest 2004 Jul;84(7):923-31

Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's Medical School, Charterhouse Square, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/3700093
Publisher Site
http://dx.doi.org/10.1038/labinvest.3700093DOI Listing
July 2004

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Cancer 2004 Jun;100(11):2387-95

Department of Viruses, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20213DOI Listing
June 2004

Progress and challenges in screening for early detection of ovarian cancer.

Mol Cell Proteomics 2004 Apr 5;3(4):355-66. Epub 2004 Feb 5.

Department of Gynaecological Oncology, Cancer Institute, Bart's and The London, Queen Mary's School of Medicine & Dentistry, London EC1M 6GR, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.R400006-MCP200DOI Listing
April 2004

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.

J Pathol 2003 Dec;201(4):544-54

Department of Gynaecological Oncology, Cancer Research UK Translational Oncology Laboratory, St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://cdn.intechopen.com/pdfs/27775.pdf
Web Search
http://doi.wiley.com/10.1002/path.1467
Publisher Site
http://dx.doi.org/10.1002/path.1467DOI Listing
December 2003

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.

Gynecol Oncol 2003 Oct;91(1):218-25

ICRF Translational Oncology Laboratory, St. Bartholomew's and the Royal London Medical and Dental School, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(03)00505-5DOI Listing
October 2003

Characterization of adnexal mass lesions on MR imaging.

AJR Am J Roentgenol 2003 May;180(5):1297-304

Department of Diagnostic Imaging, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, England, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.180.5.1801297DOI Listing
May 2003

Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases.

Int J Cancer 2002 Jun;99(4):549-54

Gynaecological Oncology Unit, St. Bartholomew's and Royal London Hospitals Medical College, Queen Mary and Westfield College, Charterhouse Square, London EC1M 6GM, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10362DOI Listing
June 2002

Ovarian cancer screening.

Hosp Med 2002 Apr;63(4):210-3

Department of Gynaecological Oncology, St Bartholomew's and the Royal London Medical and Dental School, London EC1A 7BE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hosp.2002.63.4.2038DOI Listing
April 2002

MR imaging of carcinoma of the vulva.

AJR Am J Roentgenol 2002 Feb;178(2):373-7

Department of Diagnostic Imaging, St. Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.178.2.1780373DOI Listing
February 2002